Dark

SNSS
Sunesis Pharmaceuticals, Inc. Common Stock
stock NASDAQ

Inactive

Feb 25, 2021

13.50USD+153.759%(+8.18)622,246

Pre-market

0.00USD-100.000%(-5.32)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

CEO

Dayton Misfeldt

Headquarters

South San Francisco, California, USA

Industry

Biotechnology

Last Split

Feb 25, 20212for7reverse

CELG SGEN SPPI BIIB STML FBIO CYCC XLV

Profile

Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.

.dark-mode .pDRrTS{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .pDRrTS{ color: #333333; background-color: white; border: 2px solid #333333; }SNSSSunesis Pharmaceuticals, Inc. Common Stockstock NASDAQ

SNSS
Sunesis Pharmaceuticals, Inc. Common Stock
stock NASDAQ